window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Drug Discovery & Development,Opinion & Events,Uncategorised

    SpotitEarly targets US market with AI-canine breath test for early cancer detection

    A biotech company combining artificial intelligence with canine scent detection [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    myTomorrows tops 15,000 global patient matches for pre-approval treatment access

    Clinical trial platform’s AI and navigator-led model bridges gap in [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Flexibility and precision: How Phastar is driving innovation in clinical trials

    As the pharmaceutical industry marks World Clinical Trials Day 2025, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Patient priorities must shape trial design, says One2Treat lead

    To mark Clinical Trials Day, Discover Pharma speaks with Tom [...]

    May 5, 2026
  • Biotech & Pharma Business,Opinion & Events

    Palomar Health secures record $50M to build landmark behavioral health institute in San Diego county

    In a major boost to California’s mental health infrastructure, the [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Fixing the gender gap in clinical trials

    Dr Anita Phung, GP and medical monitor at Lindus Health, [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    START’s early-phase network supports first-in-human cancer immunotherapy trial targeting solid tumors

    The START Center for Cancer Research has dosed the first [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Phesi analysis reveals colorectal cancer has highest volume of real-world data — but oncology trials remain outdated

    A new analysis by clinical data analytics firm Phesi reveals [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    Pharma giants eye obesity trial boom — but are they ready for what comes next?

    May 5, 2026
  • Biotech & Pharma Business,Opinion & Events

    Crown Bioscience extends partnership with NEXT Oncology to advance cancer research

    May 5, 2026
Previous151617Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • PRISM ALS initiative develops patient-derived stem cell models to improve ALS/MND drug discovery
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Proxygen appoints Chiara Conti as chief scientific officer to support move into clinical-stage development
    Categories: Biotech & Pharma Business, Drug Discovery & Development
  • Efzimfotase alfa shows mixed Phase 3 results in hypophosphatasia across pediatric and adult patients
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top